Get the Stockscreener App
1.50
2.04%
0.03
Pre-market:
1.50
Opko Health Inc stock is traded at $1.50, with a volume of 2.37M.
It is up +2.04% in the last 24 hours and down -2.60% over the past month.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
See More
Previous Close:
$1.47
Open:
$1.48
24h Volume:
2.37M
Relative Volume:
0.62
Market Cap:
$1.01B
Revenue:
$711.41M
Net Income/Loss:
$-133.73M
P/E Ratio:
-7.8947
EPS:
-0.19
Net Cash Flow:
$-199.99M
1W Performance:
+1.35%
1M Performance:
-2.60%
6M Performance:
+0.67%
1Y Performance:
+50.45%
1-Day Range:
$1.47
$1.51
1-Week Range:
$1.4501
$1.52
52-Week Range:
$0.8601
$1.76
Opko Health Inc Stock (OPK) Company Profile
Name
Opko Health Inc
Sector
Industry
Phone
305-575-4181
Address
4400 BISCAYNE BLVD., MIAMI, FL
Compare OPK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.50 | 1.01B | 711.41M | -133.73M | -199.99M | -0.19 |
|
TMO
Thermo Fisher Scientific Inc
|
573.06 | 219.20B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
244.11 | 176.31B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
152.57 | 43.57B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
205.69 | 37.33B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
427.33 | 34.99B | 3.84B | 866.24M | 792.60M | 10.37 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-29-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Dec-15-22 | Initiated | H.C. Wainwright | Buy |
| Jan-24-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jun-21-21 | Initiated | Ladenburg Thalmann | Buy |
| Nov-25-19 | Initiated | Piper Jaffray | Overweight |
| Mar-02-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Sep-14-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-21-16 | Reiterated | Standpoint Research | Buy |
| Jun-03-16 | Initiated | Standpoint Research | Buy |
| Mar-31-16 | Reiterated | Barrington Research | Outperform |
| Oct-16-15 | Initiated | JP Morgan | Overweight |
| Sep-11-15 | Downgrade | Jefferies | Buy → Hold |
| Mar-03-15 | Downgrade | Oppenheimer | Outperform → Perform |
| May-12-14 | Reiterated | Oppenheimer | Outperform |
| Mar-14-14 | Initiated | Oppenheimer | Outperform |
| Nov-13-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-30-13 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-22-12 | Initiated | Barrington Research | Outperform |
| Dec-01-11 | Reiterated | Ladenburg Thalmann | Buy |
| Jul-14-11 | Initiated | Ladenburg Thalmann | Buy |
View All
Opko Health Inc Stock (OPK) Latest News
OPKO Health, Inc. (OPK) Stock: An Under $5 Gem with Biggest Upside Potential - Yahoo Finance
12 Stocks Under $5 With Biggest Upside Potential - Insider Monkey
Here's Why You Should Retain OPKO Health Stock in Your Portfolio - MSN
Opko health CEO Phillip Frost buys $220,425 in common stock - MSN
OPKO Health : Immediate Report -January 18, 2025 at 06:29 am EST - Marketscreener.com
BioReference faces $704,349 fine for medically unnecessary blood tests - MSN
Phillip Md Et Al Frost Purchases 150,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock - MarketBeat
BioReference Health and OPKO Health Agree to Pay $704,349 to Settle Allegations that they Billed the - U.S. Politics Today
Opko health CEO Phillip Frost buys $220,425 in common stock By Investing.com - Investing.com Nigeria
BioReference Health, OPKO Health Settle False Claims Violations - Bloomberg Law
Barclays PLC Acquires 329,870 Shares of OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Opko health CEO Phillip Frost buys $740,850 in stock By Investing.com - Investing.com Canada
Opko health CEO Phillip Frost buys $740,850 in stock - Investing.com India
OPKO Health, Inc. (NASDAQ:OPK) CEO Buys $740,000.00 in Stock - MarketBeat
Opko Health Engages Investors at J.P. Morgan Conference - TipRanks
OPKO Health (NASDAQ:OPK) Stock Rating Lowered by StockNews.com - MarketBeat
OPKO Health Announces Progress in EBV Vaccine Study, Stock Gains - MSN
OPKO Health, Inc.'s (NASDAQ:OPK) Share Price Could Signal Some Risk - Simply Wall St
OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire
Opko Health stock buy rating reaffirmed, steady target on clinical trial - Investing.com Canada
OPKO Health's (OPK) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
OPKO Health (NASDAQ:OPK) Upgraded by StockNews.com to "Hold" Rating - MarketBeat
OPKO Health’s ModeX Therapeutics Announces Epstein-Barr - GlobeNewswire
OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck - Yahoo Finance
OPKO Health (NASDAQ:OPK) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Stake Cut by Geode Capital Management LLC - MarketBeat
3 Stocks That Wall Street Insiders Can't Stop Buying - MSN
3 Stocks That Wall Street Insiders Can’t Stop Buying - sharewise
Opko Health Inc (OPK-Q) QuotePress Release - The Globe and Mail
OPKO Health, Inc. (NASDAQ:OPK) Short Interest Down 14.0% in December - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Shares Sold by State Street Corp - MarketBeat
OPKO Health (NASDAQ:OPK) Downgraded to Sell Rating by StockNews.com - MarketBeat
OPKO Health delivers 57% gain after January Fair Value signal flags undervaluation - Investing.com Canada
Esoteric Testing Market is Set to Experience a Revolutionary Growth | Labcorp, Quest Diagnostics, OPKO Health - openPR
Connected Drug Delivery Devices Market is Dazzling Worldwide - openPR
OPKO Health (NASDAQ:OPK) Raised to Hold at StockNews.com - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) CEO Buys $198,750.00 in Stock - MarketBeat
Phillip Frost Buys Handful Of Shares In OPKO Health - Simply Wall St
Opko health CEO Phillip Frost buys $199,375 in stock By Investing.com - Investing.com South Africa
Opko health CEO Phillip Frost buys $199,375 in stock - Investing.com
Opko Health stock hits 52-week high of $1.75 amid growth - Investing.com Canada
Opko Health Inc Stock (OPK) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):